DOGLIOTTI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 1.473
EU - Europa 1.291
AS - Asia 669
OC - Oceania 67
SA - Sud America 60
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.587
Nazione #
US - Stati Uniti d'America 1.407
IT - Italia 322
CN - Cina 228
GB - Regno Unito 128
IE - Irlanda 119
FR - Francia 116
SE - Svezia 111
SG - Singapore 101
AT - Austria 94
DE - Germania 91
IN - India 78
AU - Australia 60
VN - Vietnam 42
CH - Svizzera 40
UA - Ucraina 39
JP - Giappone 38
TH - Thailandia 36
CA - Canada 34
MX - Messico 29
BE - Belgio 28
ID - Indonesia 26
PL - Polonia 26
BR - Brasile 25
NL - Olanda 23
RU - Federazione Russa 23
ES - Italia 22
HK - Hong Kong 20
PT - Portogallo 20
FI - Finlandia 18
MY - Malesia 18
CZ - Repubblica Ceca 17
GR - Grecia 15
IL - Israele 13
TR - Turchia 12
CL - Cile 11
SN - Senegal 11
KR - Corea 9
TW - Taiwan 9
AR - Argentina 8
IR - Iran 7
NZ - Nuova Zelanda 7
BY - Bielorussia 6
PE - Perù 6
HR - Croazia 5
HU - Ungheria 5
KZ - Kazakistan 5
MA - Marocco 5
PH - Filippine 5
BG - Bulgaria 4
BO - Bolivia 4
NG - Nigeria 4
OM - Oman 4
UZ - Uzbekistan 4
DK - Danimarca 3
EE - Estonia 3
EG - Egitto 3
PS - Palestinian Territory 3
RO - Romania 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
ZA - Sudafrica 3
BD - Bangladesh 2
CO - Colombia 2
KW - Kuwait 2
LU - Lussemburgo 2
NO - Norvegia 2
PR - Porto Rico 2
AE - Emirati Arabi Uniti 1
CU - Cuba 1
EC - Ecuador 1
EU - Europa 1
IQ - Iraq 1
JO - Giordania 1
LI - Liechtenstein 1
LT - Lituania 1
MN - Mongolia 1
SI - Slovenia 1
Totale 3.587
Città #
Chandler 200
Dublin 115
Beijing 112
Fairfield 96
Torino 90
Vienna 87
Ashburn 80
Singapore 73
Houston 62
Nyköping 56
Ann Arbor 45
Seattle 44
Wilmington 42
Cambridge 35
Woodbridge 35
Redwood City 33
Dearborn 28
Turin 28
Medford 27
Sydney 27
Princeton 26
Villeurbanne 26
Jakarta 24
Fremont 23
Rome 22
London 17
Milan 17
Boston 16
Guangzhou 16
Pisa 14
Washington 14
Bangkok 12
Chennai 12
Dong Ket 12
Hangzhou 12
Zurich 12
Brisbane 11
Lisbon 11
Munich 11
Jacksonville 10
New York 10
Paris 10
Rochester 10
São Paulo 10
Warsaw 10
Berlin 9
Brno 9
Melbourne 9
Santa Clara 9
Toronto 9
Athens 8
Frankfurt am Main 8
Hat Yai 8
Lausanne 8
Moscow 8
Nanjing 8
Norwalk 8
Philadelphia 8
San Diego 8
San Mateo 8
Taipei 8
Utrecht 8
Brussels 7
Hanoi 7
Hebei 7
Hefei 7
Kuala Lumpur 7
Mumbai 7
Istanbul 6
Lima 6
Mexico City 6
Naples 6
Sagunto 6
Santiago 6
Seoul 6
Bergamo 5
Buenos Aires 5
Buffalo 5
Central 5
Crowborough 5
Duncan 5
Hendon 5
Los Angeles 5
Meieki 5
Miami 5
Montreal 5
Shanghai 5
Tel Aviv 5
Zagreb 5
Adelaide 4
Alfortville 4
Barcelona 4
Battersea 4
Belo Horizonte 4
Bologna 4
Bordeaux 4
Brasília 4
Cardiff 4
Central District 4
Chengdu 4
Totale 2.022
Nome #
ABVD vs BEACOPP escalated in advanced-stage Hodgkin’s lymphoma: Results from a multicenter European study 1.217
A retrospective study of R-DHAP/Ox for early progressing follicular lymphoma. 210
Highly sensitive MYD88 l265p mutation detection by droplet digital polymerase chain reaction in waldenström macroglobulinemia 191
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice 136
CALR-positive myeloproliferative disorder in a patient with Ph-positive chronic myeloid leukemia in durable treatment-free remission: a case report 125
New Molecular Technologies for Minimal Residual Disease Evaluation in B-Cell Lymphoid Malignancies 124
COMPARISON OF DROPLET DIGITAL PCR AND STANDARD PCR IN CHRONIC MYELOID LEUKEMIA PATIENTS IN MR4 111
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis 106
TYROSINE KINASE INHIBITORS DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS OF 208 ITALIAN PATIENTS 98
MYD88L265P MUTATION DETECTION IN WALDENSTRÖM MACROGLOBULINEMIA BY DROPLET DIGITAL PCR: MINIMAL RESIDUAL DISEASE MONITORING AND CHARACTERIZATION ON CIRCULATING FREE DNA 95
IMATINIB DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS ON PATIENTS IN CLINICAL PRACTICE 88
EARLY BCR-ABL REDUCTION IS PREDICTIVE OF BETTER EVENT FREE SURVIVAL IN CHRONIC MYELOID LEUKEMIA NEWLY DIAGNOSED PATIENTS TREATED WITH ANY TKIS 87
IMATINIB DISCOTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS ON 28 UNSELECTED PATIENTS 87
The Engineered MIPI (e-MIPI), a Candidate Data-Mining Based Mantle Cell Lymphoma Prognostic Index Developed from the Dataset of the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial 86
Real life use of bendamustine in elderly patients with lymphoid neoplasia 83
Droplet Digital PCR Assay for MYD88L265P 81
MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL) 75
STANDARD AND HIGH SENSITIVITY MOLECULAR ANALYSIS IN CHRONIC MYELOID LEUKEMIA PATIENTS CANDIDATE TO DISCONTINUATION OF TYROSINE KINASE INHIBITORS 70
Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor 67
PERSONALIZED MEDICINE IN LYMPHOMA: TAILORING TREATMENT ACCORDING TO MINIMAL RESIDUAL DISEASE 63
COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment 57
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation 55
Update on emerging treatments for chronic myeloid leukemia 54
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma 53
Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience 51
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies 44
MYD88L265P Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation 42
SARS-CoV-2 infection in a stem cell transplant recipient grafted from a SARS-CoV-2-positive donor 23
Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-up 22
Sorafenib maintenance after hematopoietic stem cell transplantation improves outcome of FLT3-ITD-mutated acute myeloid leukemia 20
Cost-Effectiveness of Targeted Prophylaxis among Allogenic Stem Cell Transplant Recipients 18
Molecular remission is an independent predictor of progression-free survival in patients with Waldenström macroglobulinemia treated with chemo-immunotherapy: Results from the FIL_BIOWM study 16
Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia 15
Bacterial Bloodstream Infections after Allogeneic Hematopoietic Stem Cell Transplantation: Etiology, Risk Factors and Outcome in a Single-Center Study 15
Expert opinion on emerging drugs for lung chronic graft-versus-host disease 13
Graft-Versus-Host Disease Prophylaxis with Antithymocyte Globulin in Patients Receiving Stem Cell Transplantation from Unrelated Donors: An Observational Retrospective Single-Center Study 7
Totale 3.705
Categoria #
all - tutte 10.777
article - articoli 0
book - libri 0
conference - conferenze 2.282
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.059


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020285 0 0 0 24 11 29 31 29 31 43 34 53
2020/2021398 53 29 32 9 32 24 13 20 21 29 46 90
2021/2022691 34 30 47 73 59 46 50 51 47 54 126 74
2022/2023918 64 78 33 72 92 180 70 70 89 33 77 60
2023/2024714 47 101 60 60 82 77 55 53 9 37 59 74
2024/2025234 40 56 103 35 0 0 0 0 0 0 0 0
Totale 3.705